CLINICAL_TRIALS
research
· 2026-04-17
Clinical Trial Update: Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations [Phase 1]
Summary
Duke University is conducting a Phase 1 clinical trial to investigate senolytic properties in combination with pulmonary rehabilitation and Metformin for COPD e…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: NOT_YET_RECRUITING